SCHEMBL16355269

SCHEMBL16355269

c1ccc(-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccc(-c5ccc(-c6c7ccccc7c(-c7cccc8ccccc78)c7ccccc67)cc5)cc4)n3)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.51
SMN1; SMN2 Q16637 5/20 0.51
ALDH1A1 P00352 5/20 0.51
HPGD P15428 5/20 0.51
KDM4E B2RXH2 3/20 0.51
MAPK1 P28482 2/20 0.51
HSD17B10 Q99714 2/20 0.51
ATM Q13315 2/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
TSHR P16473 2/20 0.51
TP53 P04637 1/20 0.51
NFKB1 P19838 1/20 0.51
NFKB2 Q00653 1/20 0.51
RELA Q04206 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
RAB9A P51151 3/20 0.41
NPC1 O15118 2/20 0.41
LMNA P02545 2/20 0.41
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16355276 1.00 MAPT (0.51) MAPTSMN1; SMN2ALDH1A1HPGDKDM4E
SCHEMBL16355277 1.00 MAPT (0.51) MAPTSMN1; SMN2ALDH1A1HPGDKDM4E
SCHEMBL21309285 0.98 MAPT (0.53) MAPTSMN1; SMN2ALDH1A1HPGDKDM4E
SCHEMBL16355275 0.97 MAPT (0.49) MAPTSMN1; SMN2ALDH1A1HPGDKDM4E
SCHEMBL16355274 0.95 MAPT (0.50) MAPTSMN1; SMN2ALDH1A1HPGDKDM4E
SCHEMBL22766696 0.94 ALDH1A1 (0.47) MAPTSMN1; SMN2ALDH1A1HPGDKDM4E
SCHEMBL22766462 0.93 MAPT (0.51) MAPTSMN1; SMN2ALDH1A1HPGDKDM4E
SCHEMBL22766642 0.93 MAPT (0.51) MAPTSMN1; SMN2ALDH1A1HPGDKDM4E
SCHEMBL12133915 0.93 ALDH1A1 (0.46) MAPTSMN1; SMN2ALDH1A1HPGDKDM4E
SCHEMBL22766662 0.92 MAPT (0.48) MAPTSMN1; SMN2ALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9825244-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-21 US disclosed
US-9825244-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-21 US disclosed
US-20160308157-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO LTD (KR) 2016-10-20 US disclosed
US-20160308157-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO LTD (KR) 2016-10-20 US disclosed
US-9385336-B2 Organic light-emitting device using a mixture of electron transporting compounds SAMSUNG DISPLAY CO., LTD. (KR) 2016-07-05 US disclosed
US-9385336-B2 Organic light-emitting device using a mixture of electron transporting compounds SAMSUNG DISPLAY CO., LTD. (KR) 2016-07-05 US disclosed
US-20140374713-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2014-12-25 US disclosed
US-20140374713-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2014-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160308157-A1 ORGANIC LIGHT-EMITTING DEVICE ELMO1, ESR2, ELP1 MAPT 1382/4885SMN1; SMN2 1568/4885ALDH1A1 163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.